211 related articles for article (PubMed ID: 27404676)
1. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry.
Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Damasceno A; Keates AK; Stewart S; Sliwa K
Int J Cardiol; 2016 Oct; 221():205-11. PubMed ID: 27404676
[TBL] [Abstract][Full Text] [Related]
2. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
3. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa.
Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Ibrahim AS; Burton R; Damasceno A; Stewart S; Sliwa K
BMJ Open; 2014 Oct; 4(10):e005950. PubMed ID: 25763797
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).
Thienemann F; Katoto PDMC; Azibani F; Kodogo V; Mukasa SL; Sani MU; Karaye KM; Mbanze I; Mocumbi AO; Dzudie A; Sliwa K
Open Forum Infect Dis; 2022 Dec; 9(12):ofac604. PubMed ID: 36601555
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension.
Fine NM; Chen L; Bastiansen PM; Frantz RP; Pellikka PA; Oh JK; Kane GC
Circ Cardiovasc Imaging; 2013 Sep; 6(5):711-21. PubMed ID: 23811750
[TBL] [Abstract][Full Text] [Related]
7. Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension.
Douwes JM; Hegeman AK; van der Krieke MB; Roofthooft MT; Hillege HL; Berger RM
Int J Cardiol; 2016 Jan; 202():34-9. PubMed ID: 26386916
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictive value of electrocardiographic abnormalities in pulmonary hypertension: evidence from the Pan-African Pulmonary Hypertension Cohort (PAPUCO) study.
Balieva I; Dzudie A; Thienemann F; Mocumbi AO; Karaye K; Sani MU; Ogah OS; Voors AA; Kengne AP; Sliwa K
Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):370-376. PubMed ID: 29019518
[TBL] [Abstract][Full Text] [Related]
9. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
11. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.
Gall H; Felix JF; Schneck FK; Milger K; Sommer N; Voswinckel R; Franco OH; Hofman A; Schermuly RT; Weissmann N; Grimminger F; Seeger W; Ghofrani HA
J Heart Lung Transplant; 2017 Sep; 36(9):957-967. PubMed ID: 28302503
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.
Delcroix M; Lang I; Pepke-Zaba J; Jansa P; D'Armini AM; Snijder R; Bresser P; Torbicki A; Mellemkjaer S; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Jaïs X; Ambroz D; Treacy C; Morsolini M; Jenkins D; Lindner J; Dartevelle P; Mayer E; Simonneau G
Circulation; 2016 Mar; 133(9):859-71. PubMed ID: 26826181
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertension.
Kassem E; Humpl T; Friedberg MK
Am Heart J; 2013 Jun; 165(6):1024-31. PubMed ID: 23708176
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
[TBL] [Abstract][Full Text] [Related]
15. RV stroke work in children with pulmonary arterial hypertension: estimation based on invasive haemodynamic assessment and correlation with outcomes.
Di Maria MV; Younoszai AK; Mertens L; Landeck BF; Ivy DD; Hunter KS; Friedberg MK
Heart; 2014 Sep; 100(17):1342-7. PubMed ID: 24780910
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension as seen in a rural area in sub-Saharan Africa: high prevalence, late clinical presentation and a high short-term mortality rate during follow up.
Dzudie A; Dzekem BS; Tchoumi CT; Aminde LN; Mocumbi AO; Abanda M; Thienemann F; Kengne AP; Sliwa K
Cardiovasc J Afr; 2018 Jul/Aug 23; 29(4):208-212. PubMed ID: 30059129
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension.
Żyłkowska J; Kurzyna M; Florczyk M; Burakowska B; Grzegorczyk F; Burakowski J; Wieteska M; Oniszh K; Biederman A; Wawrzyńska L; Szturmowicz M; Fijałkowska A; Torbicki A
Chest; 2012 Dec; 142(6):1406-1416. PubMed ID: 22797193
[TBL] [Abstract][Full Text] [Related]
19. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
20. Change in Pediatric Functional Classification During Treatment and Morbidity and Mortality in Children with Pulmonary Hypertension.
Balkin EM; Olson ED; Robertson L; Adatia I; Fineman JR; Keller RL
Pediatr Cardiol; 2016 Apr; 37(4):756-64. PubMed ID: 26843461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
